Evidence map›Paper›PMID 35936273›Full record

ReviewFrontiers in psychology2022

Resilience and Protection of Health Care and Research Laboratory Workers During the SARS-CoV-2 Pandemic: Analysis and Case Study From an Austrian High Security Laboratory.

Martina Loibner, Paul Barach, Stella Wolfgruber, Christine Langner, Verena Stangl, Julia Rieger, Esther Föderl-Höbenreich, Melina Hardt, Eva Kicker, Silvia Groiss and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in psychology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. A cardiotoxicity-eliminated ACE2 variant as a pan-inhibitor against coronavirus cell invasion.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 3 countries.

Martina LoibnerDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Paul BarachDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Stella WolfgruberDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Christine LangnerDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Verena StanglDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Julia RiegerDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Esther Föderl-HöbenreichDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Melina HardtDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Eva KickerDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Silvia GroissDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Martin ZachariasDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Philipp WurmDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Gregor GorkiewiczDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Peter RegitnigDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Kurt ZatloukalDiagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
Medical University of Graz · ATUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SARS-CoV-2 pandemic has highlighted the interdependency of healthcare systems and research organizations on manufacturers and suppliers of personnel protective equipment (PPE) and the need for well-trained personnel who can react quickly to changing working conditions. Reports on challenges faced by research laboratory workers (RLWs) are rare in contrast to the lived experience of hospital health care workers. We report on experiences gained by RLWs (e.g., molecular scientists, pathologists, autopsy assistants) who significantly contributed to combating the pandemic under particularly challenging conditions due to increased workload, sickness and interrupted PPE supply chains. RLWs perform a broad spectrum of work with SARS-CoV-2 such as autopsies, establishment of virus cultures and infection models, development and verification of diagnostics, performance of virus inactivation assays to investigate various antiviral agents including vaccines and evaluation of decontamination technologies in high containment biological laboratories (HCBL). Performance of autopsies and laboratory work increased substantially during the pandemic and thus led to highly demanding working conditions with working shifts of more than eight hours working in PPE that stressed individual limits and also the ergonomic and safety limits of PPE. We provide detailed insights into the challenges of the stressful daily laboratory routine since the pandemic began, lessons learned, and suggest solutions for better safety based on a case study of a newly established HCBL (i.e., BSL-3 laboratory) designed for autopsies and research laboratory work. Reduced personal risk, increased resilience, and stress resistance can be achieved by improved PPE components, better training, redundant safety measures, inculcating a culture of safety, and excellent teamwork.

Indexed as

biosafety level-3 (BSL-3)COVID-19 pandemicoccupational challengespersonal protective equipment (PPE)research laboratory workersSARS-CoV-2

Identifiers

PMID35936273
PMCPMC9353000
OpenAlexW4286717249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.